Clovis Oncology to Announce First Quarter 2016 Financial Results and Host Webcast Conference Call on May 5

BOULDER, Colo.--(BUSINESS WIRE)-- Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its first quarter 2016 financial results on Thursday, May 5, 2016, after the close of the U.S. financial markets. Clovis’ senior management will host a conference call and live audio webcast at 4:30 p.m. ET that day to discuss the company’s results in greater detail.

The conference call is being webcast and can be accessed from the Clovis Oncology website at www.clovisoncology.com. A replay of the webcast will be available for 30 days.

About Clovis Oncology

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops diagnostic tools that direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160426005252/en/

Clovis Oncology
Breanna Burkart, 303-625-5023
[email protected]
or
Anna Sussman, 303-625-5022
[email protected]

Source: Clovis Oncology

You May Also Be Interested In

• Tesla touts acceleration of new models, but Q1 results fall short of estimates
• Avangrid (AGR) Tops Q1 EPS by 19c
• IDEX Corp. (IEX) Tops Q1 EPS by 13c ; Offers Guidance